Partnerships

We established several partnership and collaboration agreements with both regional and international institutions to advance scientific research and provide the latest therapeutic opportunities for our resident and visiting patients.

These agreements encompass the exchange of scientific expertise, research protocols, and the training of technicians and researchers.

Here are some of our key partners:

Ministry of Health:

Our Cell Therapy Center has established a strategic partnership with the Ministry of Health to advance cutting-edge medical treatments and enhance healthcare outcomes. This collaboration aims to combine our expertise in regenerative medicine with the Ministry's commitment to improving national health services. Together, we are focused on developing and implementing innovative cell therapies, conducting advanced research, and ensuring the safe and effective delivery of new treatments to patients. This partnership underscores our shared goal of transforming healthcare through scientific innovation and improving access to life-changing therapies for the public.

---------------------------------------

University of Modena and Reggio Emilia:

We formed a collaborative partnership with the University of Modena and Reggio Emilia to drive forward research and innovation in the field of regenerative medicine. This collaboration brings together our expertise in cell therapies with the university's advanced scientific research capabilities. Together, we aim to develop novel treatment options, conduct cutting-edge clinical trials, and enhance the understanding of cell-based therapies. This partnership fosters a dynamic exchange of knowledge, strengthening both academic research and practical applications in healthcare, with the goal of improving patient outcomes and advancing medical science.

---------------------------------------

University of Khartoum:

We have established a valuable partnership with the University of Khartoum to advance research and development in the field of cell-based therapies. This collaboration combines our expertise in regenerative medicine with the university's academic resources and research capabilities. Together, we aim to foster innovation, conduct joint studies, and enhance the understanding and application of cell therapies in healthcare.

---------------------------------------

Wake Forest Institute for Regenerative Medicine:

We have forged a strategic partnership with the University of Khartoum and the Wake Forest Institute for Regenerative Medicine to accelerate advancements in regenerative medicine. This collaboration combines the expertise of our center with the renowned research capabilities of both institutions. Together, we aim to pioneer innovative cell-based therapies, conduct groundbreaking research, and promote knowledge exchange in the field of regenerative medicine. This partnership strengthens global efforts to develop transformative treatments and improve patient outcomes, with a shared commitment to scientific excellence and the betterment of healthcare.

---------------------------------------

MS pharma:

Our Cell Therapy Center has formed a dynamic partnership with MS Pharma to advance the development and commercialization of innovative cell-based therapies. This collaboration leverages MS Pharma’s expertise in pharmaceutical manufacturing and distribution alongside our cutting-edge research and regenerative medicine capabilities. Together, we aim to accelerate the delivery of safe, effective therapies to patients, foster scientific innovation, and ensure broader access to transformative treatments. This partnership strengthens our collective commitment to improving healthcare outcomes and enhancing the quality of life for patients worldwide.

---------------------------------------

JFDA (Jordan Food and Drug Administration):

Our Cell Therapy Center has established a collaborative partnership with the Jordan Food and Drug Administration (JFDA) to ensure the safe and effective development and regulation of cell-based therapies. This partnership focuses on aligning with JFDA’s rigorous regulatory standards to support the clinical development and approval of innovative treatments. By working together, we aim to ensure that new therapies meet the highest safety and quality standards while improving access to cutting-edge medical solutions for patients in Jordan and beyond. This collaboration underscores our commitment to advancing healthcare through regulatory excellence and scientific innovation.

---------------------------------------

Sunmed Company:

We established a collaborative partnership with Sunmed is a company which specializing in medical products, particularly in areas related to pain management, anesthesiology, and critical care. Sunmed is engaged in developing innovative medical devices and solutions for healthcare professionals. Research within Sunmed typically focuses on improving medical practices, safety, and the efficacy of healthcare technologies.

---------------------------------------

Cellin Technologies2.jpg

Cellin Technologies :

We established a strong partnership with Cellin Technologies to drive innovation in cell-based therapies. This collaboration brings together Cellin Technologies' expertise in advanced biotechnological solutions with our focus on regenerative medicine and research. By combining our strengths, we aim to develop and scale cutting-edge cell therapies, enhance treatment outcomes, and contribute to the growing field of regenerative medicine. This partnership fosters scientific progress and accelerates the delivery of novel therapies, ultimately improving patient care and advancing healthcare solutions.

Trending

Good Manufatural Practice (GMP) is on progress

QC Validation tests for Mesenchymal Stromal Cells.

ISO 17025 in progress for hMSCs

Partnerships